Removal of pertechnetate from simulated nuclear waste streams using supported zerovalent iron

The application of nanoparticles of predominantly zerovalent iron (nanoiron), either unsupported or supported, to the separation and reduction of pertechnetate anions (TcO4-) from complex waste mixtures was investigated as an alternative approach to current waste-processing schemes. Although applicable to pertechnetate-containing waste streams in general, the research discussed here was directed at two specific potential applications at the U.S. Department of Energy's Hanford Site: (1) the direct removal of pertechnetate from highly alkaline solutions, typical of those found in Hanford tank waste, and (2) the removal of dilute pertechnetate from near-neutral solutions, typical of the eluate streams from commercial organic ion-exchange resins that may be used to remediate Hanford tank wastes. It was envisioned that both applications would involve the subsequent encapsulation of the loaded sorbent material into a separate waste form. A high surface area (>200 M2/g) base-stable, nanocrystalline zirconia was used as a support for nanoiron for tests with highly alkaline solutions, while a silica gel support was used for tests with near-neutral solutions. It was shown that after 24 h of contact time, the high surface area zirconia supported nanoiron sorbent removed about 50percent (K-d = 370 L/kg) of the pertechnetate from a pH 14 tank waste simulant containing 0.51 mM TCO4- and large concentrations of Na+, OH-, NO3-, and CO32- for a phase ratio of 360 L simulant per kg of sorbent. It was also shown that after 18 h of contact time, the silica-supported nanoiron removed>95percent pertechnetate from a neutral pH eluate simulant containing 0.076 mM TcO4_ for a phase ratio of 290 L/kg. It was determined that in all cases, nanoiron reduced the Tc(VII) to Tc(IV), or possibly to Tc(V), through a redox reaction. Finally, it was demonstrated that a mixture of 20 mass percent of the solid reaction products obtained from contacting zirconia- supported nanoiron with an alkaline waste solution containing Re(VII), a surrogate for Tc(VII), with 80 mass percent alkali borosilicate based frit heat-treated at 700 degrees C for 4 h sintered into an easily handled glass composite waste form

Removal of pertechnetate from simulated nuclear waste streams using supported zerovalent

The application of nanoparticles of predominantly zerovalent iron (nanoiron), either unsupported or supported, to the separation and reduction of pertechnetate anions (TcO 4 -) from complex waste mixtures was investigated as an alternative approach to current waste-processing schemes. Although applicable to pertechnetate-containing waste streams in general, the research discussed here was directed at two specific potential applications at the U.S. Department of Energy's Hanford Site: (1) the direct removal of pertechnetate from highly alkaline solutions, typical of those found in Hanford tank waste, and (2) the removal of dilute pertechnetate from near-neutral solutions, typical of the eluate streams from commercial organic ion-exchange resins that may be used to remediate Hanford tank wastes. It was envisioned that both applications would involve the subsequent encapsulation of the loaded sorbent material into a separate waste form. A high surface area (>200 m 2 /g) base-stable, nanocrystalline zirconia was used as a support for nanoiron for tests with highly alkaline solutions, while a silica gel support was used for tests with near-neutral solutions. It was shown that after 24 h of contact time, the high surface area zirconia supported nanoiron sorbent removed about 50% (K d ) 370 L/kg) of the pertechnetate from a pH 14 tank waste simulant containing 0.51 mM TcO 4 -and large concentrations of Na + , OH -, NO 3 -, and CO 3 2-for a phase ratio of 360 L simulant per kg of sorbent. It was also shown that after 18 h of contact time, the silica-supported nanoiron removed >95% pertechnetate from a neutral pH eluate simulant containing 0.076 mM TcO 4 -for a phase ratio of 290 L/kg. It was determined that in all cases, nanoiron reduced the Tc(VII) to Tc(IV), or possibly to Tc(V), through a redox reaction. Finally, it was demonstrated that a mixture of 20 mass % of the solid reaction products obtained from contacting zirconia-supported nanoiron with an alkaline waste solution containing Re(VII), a surrogate for Tc(VII), with 80 mass % alkali borosilicate based frit heat-treated at 700°C for 4 h sintered into an easily handled glass composite waste form

Resveratrol post-transcriptionally regulates pro-inflammatory gene expression via regulation of KSRP RNA binding activity

Resveratrol shows beneficial effects in inflammation-based diseases like cancer, cardiovascular and chronic inflammatory diseases. Therefore, the molecular mechanisms of the anti-inflammatory resveratrol effects deserve more attention. In human epithelial DLD-1 and monocytic Mono Mac 6 cells resveratrol decreased the expression of iNOS, IL-8 and TNF-α by reducing mRNA stability without inhibition of the promoter activity. Shown by pharmacological and siRNA-mediated inhibition, the observed effects are SIRT1-independent. Target-fishing and drug responsive target stability experiments showed selective binding of resveratrol to the RNA-binding protein KSRP, a central post-transcriptional regulator of pro-inflammatory gene expression. Knockdown of KSRP expression prevented resveratrol-induced mRNA destabilization in human and murine cells. Resveratrol did not change KSRP expression, but immunoprecipitation experiments indicated that resveratrol reduces the p38 MAPK-related inhibitory KSRP threonine phosphorylation, without blocking p38 MAPK activation or activity. Mutation of the p38 MAPK target site in KSRP blocked the resveratrol effect on pro-inflammatory gene expression. In addition, resveratrol incubation enhanced KSRP-exosome interaction, which is important for mRNA degradation. Finally, resveratrol incubation enhanced its intra-cellular binding to the IL-8, iNOS and TNF-α mRNA. Therefore, modulation of KSRP mRNA binding activity and, thereby, enhancement of mRNA degradation seems to be the common denominator of many anti-inflammatory effects of resveratrol